Pro Medicus Limited (AU:PME) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Pro Medicus Limited has secured a significant 5-year contract extension valued at A$32 million with a major Australian Radiology Network for its Visage RIS product. This deal reinforces the company’s market leadership in healthcare imaging solutions in Australia, showcasing its robust software offerings. Investors might find the increased fee structure promising for Pro Medicus’s future growth.
For further insights into AU:PME stock, check out TipRanks’ Stock Analysis page.